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Surgery for an anal fistula may result in recurrence or impairment of continence. The ideal treatment for an anal fistula 
should be associated with low recurrence rates, minimal incontinence and good quality of life. Because of the risk of a 
change in continence with conventional techniques, sphincter-preserving techniques for the management complex anal 
fistulae have been evaluated. First, the anal fistula plug is made of lyophilized porcine intestinal submucosa. The anal fis-
tula plug is expected to provide a collagen scaffold to promote tissue in growth and fistula healing. Another addition to 
the sphincter-preserving options is the ligation of intersphincteric fistula tract procedure. This technique is based on the 
concept of secure closure of the internal opening and concomitant removal of infected cryptoglandular tissue in the inter-
sphincteric plane. Recently, cell therapy for an anal fistula has been described. Adipose-derived stem cells have two bio-
logic properties, namely, ability to suppress inflammation and differentiation potential. These properties are useful for the 
regeneration or the repair of damaged tissues. This article discusses the rationales for, the estimated efficacies of, and the 
limitations of new sphincter-preserving techniques for the treatment of anal fistulae.
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ing reported in 34 to 63% and 2 to 26% of patients, respectively 
[10-14]. Cutting seton is also associated with significant morbid-
ity related to discomfort from the seton. Advancement flap is still 
considered to be the gold standard of treatment for a complex anal 
fistula. Successful healing of the fistula has been demonstrated in 
55 to 98% of patients [8, 10, 15-17]. However, this procedure is 
technically demanding, and although the sphincter mechanism is 
not divided during advancement flap repair of the fistula, minor 
incontinence has been found in up to 31% patients and major in-
continence in up to 12% of patients [10, 18, 19].
Because of the risk of a change in continence with these conven-
tional techniques, sphincter-preserving techniques for the man-
agement of complex anal fistulae have been evaluated. Initial stud-
ies of fibrin glue injection for the management of anal fistulae were 
promising. However, long-term results have been disappointing 
[20]. Glue was easy to apply, but probably not ideal for fistula treat-
ment because of its liquid consistency. A failure of the formed glue 
clot in a properly sealed tract, the inability to securely fix the ma-
terial within the tract and the uncertainty of tissue in growth into 
the glue may all explain the possible causes of the poor outcomes 
[21]. This article aims to review the literature and to identify the 
new sphincter-preserving techniques, such as the anal fistula plug, 
the ligation of intersphincteric fistula tract (LIFT) procedure and 
the cell therapy, used in the management of anal fistulae.
INTRODUCTION
An anal fistula is a chronic phase of anorectal sepsis and is charac-
terized by chronic purulent drainage or cyclical pain associated 
with abscess formation, followed by intermittent spontaneous de-
compression [1, 2]. The goals in the treatment of an anal fistula 
are to eliminate the primary fistula opening, any associated tracts, 
and any secondary openings without a change in continence. Most 
anal fistulae are simple and can be treated using a fistulotomy, which 
has a low recurrence rate and an acceptable rate of morbidity [3-
6]. However, the treatment of a complex anal fistula, which is de-
fined as a fistula whose treatment poses an increased risk for a 
change in continence, still represent a challenge [7-9]. The recur-
rence rate for a complex anal fistula managed with a cutting seton 
is reported to be 0 to 8%, with minor and major incontinence be-
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THE ANAL FISTULA PLUG
The small intestinal submucosa is a natural biomaterial harvested 
from porcine small intestine and fabricated into a biomedical prod-
uct of various shapes and thickness [22]. The fact that it has been 
demonstrably useful as a bioprosthetic material in infected fields 
makes its application in fistula surgery quite reasonable. The anal 
fistula plug has a biological configuration suitable for fistula dis-
ease (Fig. 1). The idea is to bridge the defect of the fistula with a 
biocompatible material that would act as a scaffold for the patient’s 
own fibroblasts to come in and promote wound healing in the fis-
tula tract [23, 24]. The technique of plug deployment is as follows: 
The tract is explored, probed, and irrigated gently with hydrogen 
peroxide. Then, the apex of the plug is tied to the probe from the 
internal opening, and the plug is dragged through to the external 
opening. It is cut to fit and is secured in the internal opening by 
using a figure-of-eight suture, incorporating it with the mucosa of 
the anorectum to close the internal opening (Fig. 2) [25]. 
The anal fistula plug has been used in a number of cases with 
widely varying results (Table 1) [21, 24, 26-33]. In an early prospec-
tive series of 46 patients reported by Champagne et al. [26], after a 
median follow-up of 12 months (range, 6 to 24 months), 17% of 
fistulae recurred. Johnson et al. [27] published a series comparing 
two prospective cohort groups of patients undergoing plug closure 
versus patients undergoing fibrin glue closure. They reported an 
87% closure rate for the plug group versus a 40% closure rate for 
the glue group. Others have had less favorable results with fistula 
recurrence rates as high as 80% [21, 28-31]. On review of these pub-
lications, possible explanations for this discrepancy include differ-
ences in patient selection and technical problems. In an attempt 
to standardize the indications for use of the bioprosthetic anal fis-
tula plug and techniques for its placement, a consensus conference 
was held in 2007. The group made a number of recommendations 
[22]. First, the group stressed that the use of the fistula plug could 
only be recommended for use in transsphincteric anal fistulae 
without acute inflammation or infection. The group felt that dis-
lodgement of the anal fistula plug was a problem related to issues 
in the technique of plug placement. The group also stressed the 
importance of the external fistula opening being patent to allow 
for drainage.
Although most fistula recurrences occur within the first 3 months 
after treatment, a significant number of recurrences are known to 
Fig. 1. Anal fistula plug.
A C B
Fig. 2. Technical steps of anal fistula plug deployment: (A) identification of the fistula tract, (B) the plug being pulled through the internal open-
ing until it is seated, and (C) the plug being secured in the internal opening by using a figure-of-eight suture.
Table 1. Outcomes with the use of the anal fistula plug
Author Fistula healing, no. (%) Follow-up (mo)
Champagne et al. [26] 38/46 (83) 12
Johnson et al. [27] 13/15 (87)   3
van Koperen et al. [28] 7/17 (41)   7
Garg [29] 17/23 (71)   9
Thekkinkattil et al. [30] 19/43 (44) 11
Ky et al. [31] 24/45 (55)   6
Christoforidis et al. [32] 12/37 (32)   6
Lawes et al. [21] 4/17 (24)   7
Ellis et al. [33] 48/78 (76) >12
Lenisa et al. [24] 36/60 (60) 13.5Journal of The Korean Society of
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occur after this time. A minimum one-year follow-up is generally 
accepted as being needed to justify the results of sphincter-preserv-
ing surgery. Ellis et al. [33] reported that posterior fistula location, 
tobacco smoking, and a history of previous failure of the plug were 
independent predictors of plug failure.
The main limitation of application of the anal fistula plug in the 
treatment of anal fistulae in Korea is the high cost. In Korea, the 
cost of an anal fistula plug is not reimbursed by the national in-
surance system. Therefore, the cost of using a plug must be paid 
by the patients themselves. The other limitation of the anal fistula 
plug is the restrictive indication. It is interesting to note that the 
anal fistula plug procedure would probably be suitable for a low 
transsphincteric fistula. In a study from the University of Minne-
sota [32], the only variable that correlated with treatment outcome 
was the amount of sphincter involved. The overall success rate was 
31%. However, it was 65% for fistulae that involved less than one-
third of the sphincter and 22% for those involving two-thirds or 
more.
LIFT PROCEDURE
Recent reports from Chulalongkorn University, Bangkok, Thai-
land, have described a novel technique called LIFT for the treat-
ment of anal fistulae. A success rate of 94.4% was reported in the 
treatment of 18 patients [34, 35]. This technique prevents the en-
try of fecal material into the fistula tract and eliminates the forma-
tion of a septic nidus in the intersphincteric space to allow healing 
of the anal fistula. Detailed technical steps of the LIFT procedure 
are as follows (Fig. 3) [35]. The location of internal opening is iden-
tified by injection of hydrogen peroxide or water through the ex-
ternal opening or by gently probing the fistula tract. A 1.5 to 2.0 cm 
curvilinear incision is made at the intersphincteric groove overly-
ing the fistula tract. The dissection is kept close to the external 
sphincter to avoid cutting through the internal sphincter and breach-
ing the anal mucosa. After the intersphincteric tract has been iden-
tified and dissected out, the tract is ligated close to the internal 
sphincter. Secure ligation of the intersphincteric tract abutting the 
internal opening is the key to success. The tract next to the suture 
site is divided, and the rest of intersphincteric tract is excised. After 
removal of the correct fistulous tract has been confirmed, infected 
granulation tissues in the rest of the tract and cavity are thoroughly 
removed with curettage. The open defect at the external anal sphinc-
ter is sutured through the intersphincteric wound. Finally, the in-
cision wound is closed loosely. 
The LIFT procedure has been used in five case series with prom-
ising early results (Table 2) [34, 36-39]. Shanwani et al. [36] reported 
that primary healing was achieved in 82.2% of the 45 patients. Ble-
ier et al. [37] reported that successful fistula closure was achieved 
in 57% of the 35 patients. No patient reported any subjective com-
promise in continence after the procedure. The advantages of the 
LIFT procedure may include preservation of the anal sphincter, 
minimal tissue injury, shorter healing time, and its being a proce-
dure that is relatively easy to perform. Additionally, even if the fis-
tula is not healed successfully, the LIFT procedure may convert a 
difficult-to-treat transsphincteric fistula into an easier-to-manage 
intersphincteric fistula.
Table 2. Outcomes with the ligation of intersphincteric fistula tract 
procedure
Author No.
Success 
(%)
Inconti-
nence
Mean  
follow-up (mo)
Rojanasakul et al. [34] 18 94.0 0 -
Shanwani et al. [36] 45 82.2 0   9
Bleier et al. [37] 39 57.0 0   5
Aboulian et al. [38] 22 77.0 0 2-15
Tan et al. [39] 55 76.4 0 24
A B
Fig. 3. Illustration of the ligation of intersphincteric fistula tract procedure. (A) After identification of the internal opening, the fistula tract is 
dissected free in the intersphincteric space. (B) The intersphincteric tract is ligated and divided.Journal of The Korean Society of
Coloproctology
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However, a number of questions remain unanswered. First, the 
published results are the only case series of a heterogeneous popu-
lation, and the good results may come from selection bias. Second, 
there were some variations in the manner in which the fistula was 
ligated and in the coring out or curettage of the external tract. Third, 
a longer and objective follow-up would be a better indicator of the 
durability, and no standardized questionnaires were used pre- or 
postoperatively with respect to fecal incontinence and quality of 
life [37]. Additionally, as is the anal fistula plug, the indication for 
the LIFT procedure seems to be limited to the transsphincteric 
fistula. The LIFT procedure for a high transsphincteric or supra-
sphincteric fistula may be technically difficult. Interestingly, an-
other intersphincteric approach for the treatment of a complex 
anal fistula has been described by Matos et al. [40]. Rojanasakul 
[35] reported two major differences between the LIFT and the 
previously described technique. First, the ligation of the fistula 
tract is more secure than over sewing, and second, removal of in-
fected granulation tissue by curettage is more practical and less 
time-consuming than total excision of the tract and primary re-
pair. Apart from the difficulty in the LIFT procedure for a high 
transsphincteric or a suprasphincteric fistula, the identification of 
the intersphincteric tract through the intersphincteric approach 
seems to require more advanced technical skills than the removal 
of the intersphincteric tract and infected granulation tissue in a 
conventional technique does.
BIOLIFT PROCEDURE
Neal Ellis [41] published outcomes with the BioLIFT technique 
for the management of transsphincteric fistulae. He reported that 
the success rate was 94% of 31 patients. The BioLIFT technique is 
a variation of the LIFT technique in which a bioprosthetic is placed 
in the intersphincteric plane to reinforce the closure of the fistula 
tract. The bioprosthetic graft acts as a physical barrier in the inter-
sphincteric space. Actually, the BioLIFT technique utilized a tran-
section of the intersphincteric tract and closure of the fistula open-
ing in the internal sphincter, which is similar to the procedure de-
scribed by Matos et al. [40], instead of ligating the intersphincteric 
tract. When compared to the LIFT, the BioLIFT technique has two 
potential disadvantages. First, it requires a more extensive dissec-
tion in the intersphincteric space because the bioprosthetic must 
overlap the closure of the fistula tract by at least 1 to 2 cm in all di-
rections. The second disadvantage is the relatively high cost of the 
bioprosthetic materials.
EXPANDED ADIPOSE-DERIVED STEM CELLS 
(ASCs)
Mesenchymal adult stem cells extracted from certain tissues, such 
as adipose tissue, can differentiate into various types of cell [42]. 
Garcia-Olmo et al. [43, 44] chose adipose tissue as the source of 
stem cells because of their two biologic properties: their ability to 
suppress inflammation and their differentiation potential. More-
over, enough fat can be obtained with liposuction, and the fat cells 
can be harvested with minimal adverse effects on the patient. Their 
phase I clinical trials show that adipose-derived stem cells are safe 
for the treatment of a fistula in Crohn’s disease [43], and they pub-
lished a phase II multicenter, randomized controlled trial to further 
investigate the effectiveness and safety of ASCs in the treatment of 
complex anal fistulae compared with the fibrin glue group [44]. 
The treatment procedures are as follows: 1) tract identification, 
with special emphasis on the identification of the internal open-
ing; 2) tract curettage, with special emphasis on the intersphinc-
teric tract; 3) closure of the internal opening; 4) injection of a cell 
suspension through a long fine needle into the tract walls; 5) seal-
ing of the tract with fibrin glue. They reported that fistula healing 
was observed in 71% of 24 patients who received ASCs in addition 
of fibrin glue compared with 16% of 25 patients who received fibrin 
glue alone (relative risk for healing, 4.43; confidence interval, 1.74 
to 11.27; P < 0.001). The proportion of patients with healing was 
similar between the Crohn’s and the non-Crohn’s subgroups.
An advantage of using stem cells to treat an anal fistula is that, 
because tract resection is not required, the treatment does not in-
jure the anal sphincter (Fig. 4). There are, nonetheless, some limi-
tations of the ASCs-based therapy. First, the cost of treatment with 
ASCs is difficult to evaluate in detail at present. Second, technically, 
secure closure of the internal opening and complete injection of 
the cell suspension over the tract may be complicated procedures. 
Finally, as yet, there are no reports on the long-term effects of us-
ing ASCs.
In the meantime, a pilot study on autologous fibroblast-based 
therapy for the treatment of anal fistulae is in progress in the United 
Kingdom [45]. In brief, the authors suggest that the addition of 
autologous fibroblasts to the filling material (collage paste) provides 
the best histologic healing.
CONCLUSION
To the colorectal surgeon, the complex anal fistula remains a chal-
lenging condition to manage despite the best of technologic ad-
A B
Fig. 4. Fistula (A) before and (B) eight weeks after the injection of ad-
ipose-derived stem cells.Journal of The Korean Society of
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vances. Therefore, the colorectal surgeon should become familiar 
with various new techniques for treating an anal fistula and remem-
ber that conventional fistula surgery, such as cutting seton and 
advancement flap, has an important role. Especially, the advance-
ment flap is still the gold standard of treatment for complex anal 
fistulae. Definitive evidence of the advantage of the new sphinc-
ter-preserving techniques compared with the traditional interven-
tion requires randomized control studies, which are now being 
conducted.
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